ADPT
Adaptive Biotechnologies Corporation
Stock
$28.35+0.98 (+3.58%)Close Oct 2, 2026
- Operating cash flow, 2025
- −$46M
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | −$46M | — |
| 2024 | −$95M | — |
| 2023 | −$156M | — |
| 2022 | −$184M | — |
| 2021 | −$193M | — |
| 2020 | −$150M | — |
| 2019 | $205M | — |
| 2018 | −$32M | — |
| 2017 | −$35M | — |